News

mRNA Science and BioNTech

How a Once-Dismissed Idea Is Ending the Pandemic

BioNTech rose to global fame in 2020 for the successful COVID-19 vaccine they developed with Pfizer. But the vaccine is only the beginning for the German biotech. Their immunotherapy science may soon revolutionize medicine.

Pfizer and BioNTech Recruit for Large-Scale Vaccine Trial

Back in March we reported on vaccine developments by German biotechs CureVac and BioNTech. Four months later, clinical trials are underway. Together with Pfizer, BioNTech is rounding up participants for a COVID-19 vaccine trial in the U.S. Read on to find out how you can participate.

Avoiding a Viral Vacation

After more than three months at home, people are eager to get back to some semblance of normal life and to enjoy their summers, but experts and data show us we must be cautious when traveling.

Herd Immunity or Another Lockdown?

Germany Moves Ahead with Antibody Testing

Across Germany and many parts of the U.S., life is slowly starting to resume, albeit in new ways. Shops and restaurants are opening, small groups of friends are getting together and people are heading back to work. But along with the new normal comes yet another largely uncharted territory: antibody testing.

German Innovation Tackles COVID-19

The world is waiting for a breakthrough vaccine against COVID-19. The German biotechs CureVac and BioNTech are among the companies leading these efforts.